AbstractBACKGROUND:Current prognostic systems for myelodysplastic syndromes (MDS) are based on clinical, pathologic, and...
Posted by : Pr. Franck BONNETAIN
Journal name : Cancer
AbstractBackgroundWe studied the relationship between intermediate criteria and overall survival (OS) in metastatic...
Posted by : Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN
Journal name : Clinical Colorectal Cancer
Advances in cancer care delivery require revision and further development of questionnaires assessing patients’...
Posted by : Pr. Franck BONNETAIN
Journal name : European Journal of Cancer Care
AbstractBackground: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single...
Posted by : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Journal name : Breast Cancer Research
Abstract Background The overexpression of human epidermal growth factor receptor-2 (HER2) in breast cancer is a...
Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY
Journal name : BMC Cancer
We conducted a retrospective study to assess the follow-up of patients with localized breast cancer and the first...
Posted by : Mme. Aurélia MEURISSE,
Journal name : Breast
AbstractAim: Adjuvant clinical trials in early human epidermal growth factor receptor 2 (HER2)-positive breast cancer...
Posted by : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Journal name : European Journal of Cancer
Since the MOSAIC study, oxaliplatin-based adjuvant chemotherapy has been the standard treatment of stage III colon...
Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : Annals of Oncology
Background: In advanced pancreatic ductal adenocarcinoma (aPDAC), there is no consensual strategy for second-line...
Posted by : , Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Journal name : JNCI J Natl Cancer Inst
AbstractTraditionally, the efficacy of cancer treatment in patients with advance or metastatic disease in clinical...
Posted by : Pr. Franck BONNETAIN
Journal name : Annals of Oncology
ABSTRACTIntroduction: Intermediate endpoints are often used as primary endpoints instead of overall survival (OS) in...
Posted by : Pr. Franck BONNETAIN
Journal name : Expert Review of Anticancer Therapy
Background:To assess the efficacy of a patient educational program built according to guidelines that aims at reducing...
Posted by : Pr. Franck BONNETAIN
Journal name : British Journal of Cancer
Background Nab-paclitaxel plus gemcitabine has become a standard treatment regimen in patients with metastatic...
Posted by : Mme. Aurélia MEURISSE, Pr. Franck BONNETAIN
Journal name : Lancet Gastroenterology Hepatology
BackgroundEven if a large majority of out-of-hospital cardiac arrest (OHCA) survivors appear to have a good neurological...
Posted by : Pr. Franck BONNETAIN
Journal name : Resuscitation
The measurement of the quality of life in terms of health of people undergoing treatment for cancer is developing. Th is...
Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Mme. Joëlle FRITZSCH,
Journal name : La revue de l'infirmière
SummaryData in the literature regarding the care pathway of pancreatic cancer patients are limited. The objective of the...
Posted by : Pr. Franck BONNETAIN
Journal name : Bulletin du Cancer